Supplementary Balance Sheet Information

6 Months Ended

Mar. 31, 2020

Balance Sheet Related Disclosures [Abstract]

Supplementary Balance Sheet Information

Supplementary Financial Statement Information

	March 31, 2020		September 30, 2019
Inventories, net of reserves:
Finished products	$	114.3	$	120.5
Work in process	42.7		42.4
Raw materials	108.5		106.7
Total inventories, net of reserves	$	265.5	$	269.6
Accumulated amortization of software and other intangible assets	$	602.2	$	597.0
Investments included in Other assets	$	47.7	$	51.1

Investments

In the first quarter of fiscal 2019, we acquired $26.6 million of non-marketable equity securities that are valued at cost.

During the six months ended March 31, 2020, we sold an equity investment with a carrying value of $3.1 million and recognized a loss of $0.3 million, which is recorded as a component of Investment income (expense) and other, net. Additionally, we recognized an impairment loss of $1.7 million on a cost method investment. The loss was recorded as a component of Investment income (expense) and other, net.

Supplemental Cash Flow Information

	Six Months Ended March 31
	2020		2019
Non-cash investing activities:
Change in capital expenditures not paid	$	4.0	$	0.3
Sale of equity method investment	2.8		—
Total non-cash investing activities:	$	6.8	$	0.3
Non-cash financing activities:
Distribution of shares issued under stock-based compensation plans	$	27.1	$	9.9